What is the difference between activated and non-activated Platelet-Rich Plasma (PRP) therapy for an adult patient with androgenetic alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Difference Between Activated and Non-Activated PRP for Androgenetic Alopecia

Direct Answer

Non-activated PRP is superior to activated PRP and should always be used for treating androgenetic alopecia—activation reduces efficacy by 31% and should be avoided. 1, 2

Key Differences in Clinical Outcomes

Hair Density and Growth Results

  • Non-activated PRP produces 31% greater increases in hair count and total hair density compared to activated PRP in patients with androgenetic alopecia 1, 2, 3

  • In direct comparison studies, non-activated PRP achieved hair density increases of 11.2% at 2 months, 26.1% at 6 months, and 32.4% at 12 months 4

  • Activated PRP showed inferior results with only 8.1% increase at 2 months, 12.5% at 6 months, and 20.8% at 12 months 4

Mechanism Behind the Difference

  • Non-activated PRP does not require external activation before injection because the natural wound healing response and tissue trauma from the injection itself provides sufficient activation of platelets 1

  • Pre-activation with calcium chloride or other activators appears to trigger premature degranulation of growth factors before optimal tissue integration occurs 4

  • The proliferative activity of hair follicle cells and improvement in hair morphology are enhanced when PRP remains non-activated until the moment of tissue contact 1

Preparation Protocol Differences

Non-Activated PRP (Recommended)

  • Blood is collected and processed through double-spin centrifugation to achieve 1.0-1.5 million platelets per microliter 2

  • No calcium chloride, thrombin, or other activating agents are added to the preparation 1, 4

  • PRP is injected immediately after preparation without additional processing steps 2

Activated PRP (Not Recommended)

  • After initial centrifugation, a second centrifugation step is performed specifically for platelet activation 4

  • Calcium chloride or other activating agents are added to trigger platelet degranulation before injection 4, 5

  • This pre-activation step is the critical difference that reduces clinical efficacy 1, 4

Clinical Implementation

Treatment Protocol with Non-Activated PRP

  • Administer 3 intradermal scalp injection sessions spaced exactly one month apart 1, 2, 3

  • Use 5-7 mL of non-activated PRP per session with 30-gauge × 4 mm needles 2

  • Inject at 90-degree angle, 2-4 mm depth, spacing injections 1 cm apart across areas of hair loss 2

  • Always combine with topical minoxidil 5% at 1 mL twice daily throughout treatment and beyond for superior outcomes 2, 3

  • Maintenance injections every 6 months are required to sustain results 2, 3

Critical Pitfall to Avoid

The single most important clinical error is activating PRP before injection—this reduces treatment efficacy by 31% and should never be done. 1, 2, 3 The natural activation that occurs upon tissue contact is sufficient and superior to pre-activation with external agents 1

Expected Timeline with Non-Activated PRP

  • Initial improvements become visible at 2-3 months, with 25% improvement at 2 months predicting sustained response at 6 months 1, 2

  • At 6 months, expect hair density to increase by 1.74 times, hair diameter by 14.3 times, and telogen phase hair to decrease by 9.3 times 2

  • Mild to moderate androgenetic alopecia responds most favorably, with more severe grades showing variable results 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Platelet-Rich Plasma (PRP) Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Androgenetic Alopecia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.